Validation Of The Apixaban Cost-Effectiveness Model In Patients With Non-Valvular Atrial Fibrillation
Abstract
Authors
S. Kachroo H. Phatak P. Dorian T. Kongnakorn T. Lanitis A. Kuznik J. Mardekian X. Liu J. Lawrence G.Y. Lip